Biopharmaceutical Market Report

Biopharmaceutical Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2014 To 2020

  • Published Date: ---
  • Base Year for Estimate: ---
  • Report ID: 660
  • Format: Electronic (PDF)
  • Historical Data: ---
  • Number of Pages: 0

Biopharmaceuticals are drugs used for medical purposes and are produced by the extraction of proteins and nucleic acids direct from the biological source using biotechnology. Most of the biopharmaceuticals are the pharmaceutical products derived from the life forms, genetically modified plants and animals are known as transgenic organisms, and this process is used to produce biopharmaceuticals however it is a very controversial method and is still under the trail phase. Recombinant human insulin was amongst the first substances to be approved for therapeutic purpose and currently there are nearly 300 biopharmaceutical products which have been approved and are available in the market. Increasing geriatric population, growing awareness levels and rising healthcare expenditure are the few key factors which are driving the growth of this market. Furthermore approval for newer biopharmaceutical products and continuous R&D in this segment is expected to positively reinforce this market. However high prices of these drugs are one of the biggest restraints to this industry and to make it commercially viable the cost needs to be significantly reduced.

On the basis of markets, biopharmaceutical can be segmented into four categories namely biosimilar market, enzyme market, protein therapeutics market and cancer monoclonal antibodies market. Global biosimilar market has the highest market share and is expected to maintain its high growth rate for the estimated period. This industry is driven by the factors such as high pharmaceutical expenditure, and the presence of expensive drugs in this sector. Additionally global protein therapeutics market is also expected to register very high growth rate for the estimated period owing to its efficiency in target therapy which has little or no side effects. Global enzyme market and cancer monoclonal market are expected to grow at a steady pace for the forecasted period.

On the basis of geography the biopharmaceutical market can be segmented in four key regions namely North America, Europe, Asia Pacific, and RoW. North America has the highest industry share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet industry opportunities in the region.

Key players in global biopharmaceutical market are Novartis A.G., Pfizer Inc, Merck & Co. and GlaxoSmithKline Plc, Abbott Laboratories, Amgen Inc. and Biogen Idec.

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified